ResMed Inc. RMD

222.00 0.11 0.05% as of 25 Sep
Market cap
$31.9B
P/E
21.3×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years

ResMed Inc. (RMD) P/E ratio

As of 25 September 2026, ResMed Inc. (RMD) trades at a P/E ratio of 21.3×. Over the past ten years it has ranged from 17.6× (June 2026) to 90.9× (September 2021); the current reading is higher than 4% of that period. That is below the Medical Instruments & Supplies industry median of 34.2× and below the Healthcare sector median of 22.7×.

P/E ratio, daily

Annual

Period P/E ratio Change
FY2026 18.6× (31.04%)
FY2025 27.0× 0.29%
FY2024 26.9× (24.68%)
FY2023 35.8× (9.07%)
FY2022 39.3× (47.83%)
FY2021 75.4× 69.23%
FY2020 44.5× 1.87%
FY2019 43.7× (6.45%)
FY2018 46.7× 45.28%
FY2017 32.2× 24.17%

Quarterly

Period P/E ratio Change
Jun 2026 18.6× (13.68%)
Mar 2026 21.6× (9.04%)
Dec 2025 23.7× (14.95%)
Sep 2025 27.9× 3.29%
42 more quarters

Against its own ten years

Low 17.6× High 90.9×
Ten-year median 32.7×
Current reading's percentile 4

P/E ratio against peers

Company P/E ratio
BAX Baxter International Inc. compare n/m
SOLV Solventum Corporation compare 10.9×
COO The Cooper Companies, Inc. compare 18.9×
RMD ResMed Inc. 21.3×
WST West Pharmaceutical Services, Inc. compare 47.1×
ALC Alcon compare 49.2×
BDX Becton, Dickinson and Company compare 55.4×
RGEN Repligen Corporation compare 253×
MDLN Medline Inc. compare —
Medical Instruments & Supplies industry median 34.2×
Healthcare sector median 22.7×
Market median 17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on RMD